{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03601",
    "Peptide Name": "PhciCath5 (Ph. ci. cathelicidin, 1S=S, natural AMPs; marsupial, mammals, animals, UCSS1; BBMm; inactive: PhciCath1 PhciCath2; PhciCath3; PhciCath6)",
    "Source": "bone marrow,Phascolarctos cinereus, Australia",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KRGGIWKLIRPLGRGAGRILRHFHIDFCGNC",
    "Sequence Length": 31,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 1.85,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "42%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Discovery: First AMP from the Australia marsupial discovered via sequence homology search.Sequence analysis: APD analysis reveals this sequence is most similar (38.71%) toSaha-CATH5G:19%; R: 16%; I:13%. Mol. Wt: 3548.255; GRAVY: -0.22; Mol Formula: C159H258N53O35S2; mol ex coeff: 5675.Activity: in cation-adjusted Mueller Hinton Broth, active against P-aeruginosa ATCC27853 (MIC>64 ug/ml), E. coli ATCC25922 (MIC 16-64 ug/ml), S. aureus MRSA (8-16 ug/ml), S-pneumoniae ATCC49619 (MIC>64 ug/ml), S. pyogenes ATCC19615 (MIC 64 ug/ml), S. agalactiae ATCC12386 (MIC 64 ug/ml), S-dysgalactiae (MIC>64 ug/ml), S-lutetiensis (MIC>64 ug/ml), S-equi (MIC>64 ug/ml), S-oralis (MIC>64 ug/ml), S. salivarius (MIC 64 ug/ml), S. mutans (MIC>64 ug/ml), L. monocytogenes (MIC 64 ug/ml), P-multocida (MIC>64 ug/ml), K-pneumoniae (MIC >64 ug/ml), C. parapsilosis ATCC 22019 (MIC 32 ug/ml), C. krusei ATCC 6258 (MIC 64 ug/ml), C-glabrata (MIC >64 ug/ml), and C-albicans (MIC >64 ug/ml). In addition, PhciCath5 inactivated C. pecorum IPTaLE and MarsBar elementary bodies and significantly reduced the number of inclusions compared to the control (p<0.0001).Antimicrobial robustness: activity against E. coli reduced in the presence of 10% bovine serum albumin (MIC 64->175 ug/ml, serum-sensitive) or 20% whole mouse blood. MIC is also salt-sensitive (E. coli and S. aureus, MIC 11 ug/ml, without  Ca2+).MOA: membrane permeabilization.",
    "Author": "Peel E, Cheng Y, Djordjevic JT, O'Meally D, Thomas M, Kuhn M, Sorrell TC, Huston WM, Belov K.2021",
    "Reference": "PLoS One. 2021 Apr 14;16(4):e0249658. doi: 10.1371/journal.pone.0249658.PubMed",
    "Title": "Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum."
  },
  "3D Structure": []
}